Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy

NCT01129206 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of the Esophagus
Adenocarcinomas of the Gastroesophageal Junction
Recurrent Esophageal Cancer
Squamous Cell Carcinoma of the Esophagus
Stage IV Esophageal Cancer

Interventions

DRUG: pralatrexate
DRUG: docetaxel
RADIATION: fludeoxyglucose F 18
PROCEDURE: positron emission tomography

Sponsor

Ohio State University Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]